Top compounds associated with response to RWDD4


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.5
mRNA TG-101348 CTRPv2 pan-cancer AAC 0.025 0.5
mRNA lapatinib UHNBreast pan-cancer AAC 0.23 0.5
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC 0.055 0.5
mRNA salermide CTRPv2 pan-cancer AAC 0.034 0.5
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.5
mRNA CAY10576 CTRPv2 pan-cancer AAC 0.028 0.5
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA IC-87114 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC -0.026 0.5
Download CSV